GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Metro Healthcare Indonesia Tbk (ISX:CARE) » Definitions » Revenue

PT Metro Healthcare Indonesia Tbk (ISX:CARE) Revenue : Rp319,022 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PT Metro Healthcare Indonesia Tbk Revenue?

PT Metro Healthcare Indonesia Tbk's revenue for the three months ended in Dec. 2024 was Rp80,639 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was Rp319,022 Mil. PT Metro Healthcare Indonesia Tbk's Revenue per Share for the three months ended in Dec. 2024 was Rp2.43. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was Rp9.59.

During the past 12 months, the average Revenue per Share Growth Rate of PT Metro Healthcare Indonesia Tbk was 31.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 3.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 11.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 9 years, PT Metro Healthcare Indonesia Tbk's highest 3-Year average Revenue per Share Growth Rate was 90.70% per year. The lowest was 3.10% per year. And the median was 19.10% per year.


PT Metro Healthcare Indonesia Tbk Revenue Historical Data

The historical data trend for PT Metro Healthcare Indonesia Tbk's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Metro Healthcare Indonesia Tbk Revenue Chart

PT Metro Healthcare Indonesia Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Revenue
Get a 7-Day Free Trial Premium Member Only 216,296.10 290,934.36 260,426.19 242,680.80 319,022.41

PT Metro Healthcare Indonesia Tbk Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70,333.35 80,882.35 84,568.48 72,932.41 80,639.18

Competitive Comparison of PT Metro Healthcare Indonesia Tbk's Revenue

For the Medical Care Facilities subindustry, PT Metro Healthcare Indonesia Tbk's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Metro Healthcare Indonesia Tbk's Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Metro Healthcare Indonesia Tbk's Revenue distribution charts can be found below:

* The bar in red indicates where PT Metro Healthcare Indonesia Tbk's Revenue falls into.


;
;

PT Metro Healthcare Indonesia Tbk Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp319,022 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Metro Healthcare Indonesia Tbk  (ISX:CARE) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


PT Metro Healthcare Indonesia Tbk Revenue Related Terms

Thank you for viewing the detailed overview of PT Metro Healthcare Indonesia Tbk's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Metro Healthcare Indonesia Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Raya Serang Km 16,8, RT / RW 005/001, Kel. Sukamulya, Kec. Cikupa, Tangerang, IDN, 15710
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Inpatient and Outpatient. The majority of revenue is derived from the inpatient segment.